VATS Evacuation Compared to Reinsertion of Thoracostomy Tube in Persistent Traumatic Haemothorax

Hemothorax; Traumatic Clinical Trial

Official title:

Video_ Assisted Thoracoscopic Surgery Evacuation Compared to Reinsertion of Thoracostomy Tube in Persistent Traumatic Haemothorax

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03501524
• Other study ID #: 17100227
• Status: Recruiting
• Phase: N/A
• First received: April 8, 2018
• Last updated: April 16, 2018
• Start date: July 1, 2017
• Est. completion date: July 30, 2018

Study information

• Verified date: April 2018
• Source: Assiut University
• Contact: Mohammed Emad Eldin Omar
• Phone: 02010065327099
• Email: mhmd_rabab[@]yahoo.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This is prospective, randomized study comparing VATS (video- Assisted Thoracoscopy) to reinsertion of a thoracostomy tube in patients with persistent traumatic haemothorax. The incidence varies and can be as high as 20%, but in most studies is found to be 1-4% after initial tube thoracostomy for chest trauma. The most accepted complication of retained hemothorax is empyema.Retained hemothorax treatment started by physiotherapy and early withdrawal of tube thoracostomy which lead to more complications as empyema, fibro thorax/entrapped lung, flail chest and diaphragmatic hernia. Early VATS is an alternative treatment for retained hemothorax with evidence that it is a superior intervention when compared to a second tube thoracostomy.

Description:

Traumatic injuries are a significant cause of morbidity and mortality in our society.At Assiut university hospitals, chest injuries (17.7%) considered as second cause of mortality after head injuries (34.6%) of registered deaths by cause of injury at trauma unit, Assiut university hospitals in a study conducted between,2002-2009. In United States, thoracic injuries are the primary factor in approximately 35% of these deaths, one -third of which occur immediately following the injury, and are contributing in nearly 75% of trauma -related deaths. Up to 15% of patients who sustain thoracic trauma undergo emergent thoracotomy for resuscitation, massive hemothorax, cardiac tamponade, large thoracic wounds, major thoracic vascular injuries, tracheobronchial injuries, or evidence of esophageal injury. The remaining 85-90% of patients who reach the emergency department does not require emergent thoracotomy are initially managed with tube thoracostomy, pain control, pulmonary toilet, and observation .Patients failing this management ultimately require elective thoracotomy for further evaluation and treatment(clotted hemothorax, empyema and diaphragmatic hernia. The current role of VATS in trauma includes evaluation and control of continued chest tube bleeding, early evacuation of retained hemothorax, evacuation and decortication of posttraumatic empyemas, evaluation and limited treatment of suspected diaphragm injuries, evaluation and treatment of persistent air leaks, and evaluation of mediastinal injuries.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 2
• Est. completion date: July 30, 2018
• Est. primary completion date: July 30, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

We include for the study all patients admitted to Assiut university hospitals during the time of the study that proved persistent haemothorax that with criteria:

1. Ages that are eligible for study are between 18years to 60 years (adult)

2. Both genders will be included to study.

3. Clinical and radiological diagnosis of persistent haemothorax.

4. Thoracostomy tube blockage or failure to drain within 5-7days.

Exclusion Criteria:

1. More than one thoracostomy tube drainage in the same attempt side.

2. Unable to consent to trial.

3. Coexisting pathology requiring other interventions.

4. Patients that need urgent interventions (hemodynamically unstable, empyema and flail chest).

Related Conditions & MeSH terms

• Hemothorax
• Hemothorax; Traumatic

Intervention

Device:
• VATS evacuation
the patient will be randomized to a Video-Assisted thoracoscopy for retained haemothorax
• thoracostomy tube
the patient is randomized to reinsertion of a Thoracostomy Tube for retained haemothorax

Locations

Country	Name	City	State
Egypt	Assiut university	Assiut

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Duration of hospitalization	number of days spent	average 5-7 days
Secondary	number of patients developed empyema	the study will be monitored for septic complications , specially empyema.	through one month